Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 5/20 | 0.47 |
| ▸ | KCNN4 | O15554 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | JAK2 | O60674 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4158606 | 0.75 | ALDH1A1 (0.39) | KCNA5KCNN4ESR1HTTALDH1A1 | |
| SCHEMBL9463336 | 0.72 | NPC1 (0.51) | MEN1KMT2ANPSR1NPC1JAK2 | |
| SCHEMBL9462924 | 0.72 | NPC1 (0.51) | MEN1KMT2ANPSR1NPC1JAK2 | |
| SCHEMBL9313680 | 0.71 | TP53 (0.42) | KCNA5KCNN4TP53ESR1MEN1 | |
| SCHEMBL11723546 | 0.70 | KCNA5 (0.43) | KCNA5KCNN4TP53ESR1MEN1 | |
| SCHEMBL12833638 | 0.68 | TP53 (0.44) | KCNA5KCNN4TP53ESR1ALDH1A1 | |
| Diethylaniline SCHEMBL3678211 | 0.67 | TSHR (0.55) | TP53MEN1KMT2AHTTALDH1A1 | |
| Phosphoric Acid SCHEMBL29898200 | 0.67 | ALDH1A1 (0.50) | MEN1KMT2AHTTALDH1A1GLA | |
| Phosphoric Acid SCHEMBL1242659 | 0.67 | ALDH1A1 (0.50) | MEN1KMT2AHTTALDH1A1GLA | |
| SCHEMBL813181 | 0.67 | SRC (0.42) | TP53MEN1KMT2AHTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 412 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199709-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | SPOGEN BIOTECH INC (US) | 2024-06-20 | — | — | US | claimed |
| US-11905315-B2 | Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria | SPOGEN BIOTECH INC. (US) | 2024-02-20 | — | — | US | claimed |
| EP-2533633-B1 | FUNGICIDAL MIXTURES | LANXESS DISTRIB GMBH (DE) | 2017-02-01 | — | — | EP | claimed |
| US-20130195997-A1 | FUNGICIDAL MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2013-08-01 | — | — | US | claimed |
| EP-2460408-A1 | Nematicidal compositions | deVGen N.V. (BE) | 2012-06-06 | — | — | EP | claimed |
| US-20110319435-A1 | FUNGICIDE MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2011-12-29 | — | — | US | claimed |
| US-20240228396-A9 | METHODS FOR PROMOTING PLANT HEALTH USING FREE ENZYMES AND MICROORGANISMS THAT OVEREXPRESS ENZYMES | SPOGEN BIOTECH INC (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240228394-A9 | METHODS FOR PROMOTING PLANT HEALTH USING FREE ENZYMES AND MICROORGANISMS THAT OVEREXPRESS ENZYMES | SPOGEN BIOTECH INC (US) | 2024-07-11 | — | — | US | disclosed |
| US-12031164-B2 | Fusion proteins, recombinant bacteria, and exosporium fragments for plant health | SPOGEN BIOTECH INC. (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240199709-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | SPOGEN BIOTECH INC (US) | 2024-06-20 | — | — | US | disclosed |
| US-20240132417-A1 | METHODS FOR PROMOTING PLANT HEALTH USING FREE ENZYMES AND MICROORGANISMS THAT OVEREXPRESS ENZYMES | SPOGEN BIOTECH INC (US) | 2024-04-25 | — | — | US | disclosed |
| US-20240132419-A1 | METHODS FOR PROMOTING PLANT HEALTH USING FREE ENZYMES AND MICROORGANISMS THAT OVEREXPRESS ENZYMES | SPOGEN BIOTECH INC (US) | 2024-04-25 | — | — | US | disclosed |
| US-20240109819-A1 | METHODS FOR PROMOTING PLANT HEALTH USING FREE ENZYMES AND MICROORGANISMS THAT OVEREXPRESS ENZYMES | SPOGEN BIOTECH INC (US) | 2024-04-04 | — | — | US | disclosed |
| US-6100281-A | MICROBIOCIDES FOR CROP PROTECTION AND PRESERVATION OF ORGANIC MATERIALS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-08-08 | — | — | US | disclosed |
| US-6090831-A | FUNGICIDE; BACTERICIDE | BAYER AKTIENGESELLSCHAFT (DE) | 2000-07-18 | — | — | US | disclosed |
| US-6054473-A | 1,3-dimethyl-5-fluoro-pyrazole-4-carboxamide derivatives, their preparation and their use as microbicides | BAYER AKTIENGESELLSCHAFT (DE) | 2000-04-25 | — | — | US | disclosed |
| US-6043377-A | MICROBICIDES USEFUL IN CROP PROTECTION AND IN THE PROTECTION OF MATERIALS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-03-28 | — | — | US | disclosed |
| US-6013664-A | REACTING THIOPHENE-2-CARBOXYLIC ACID DERIVATIVE WITH AMINE, HYDROXY OR MERCAPTO DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-01-11 | — | — | US | disclosed |
| US-6001879-A | SUITABLE FOR CONTROLLING PESTS, PREFERABLY FUNGI, INSECTS AND BACTERIA, IN PLANTS AND INDUSTRIAL MATERIALS; METHODS OF THEIR SYBNTHESIS INCLUDING REACTING AMINOSALICYLAMIDES WITH ACYLATING AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1999-12-14 | — | — | US | disclosed |
| US-5942528-A | INSECTICIDES, ARACHNICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12031164-B2 | Fusion proteins, recombinant bacteria, and exosporium fragments for plant health | ENGASE, LCT, CPB1 | KCNA5 3260/4885KCNN4 3980/4885TP53 3737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.